Primary Site >> Esophagus Cancer

Gene >> SPPL2A

  • 2012
Ref: Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.
PMID: 22776426